Podarcis wall lizards are endemic to the Mediterranean Basin the place they symbolize the predominant reptile group. Despite being extensively used as mannequin organisms in evolutionary and ecological research their phylogeny and historic biogeography are nonetheless incompletely resolved. Moreover, molecular clock calibrations utilized in wall lizard phylogeography are primarily based on the idea of vicariant speciation triggered by the abrupt Mediterranean Sea stage rise on the finish of the Messinian salinity disaster (MSC). However, the validity of this biogeographic calibration stays untested.
In this research we inferred a sturdy time tree primarily based on multilocus information and fossil calibrations utilizing each gene concatenation and species-tree approaches and together with models with gene-flow. We discovered 5 deeply divergent, geographically coherent, and well-supported clades comprising species from i) Iberian Peninsula and North Africa; ii) Western Mediterranean islands, iii) Sicilian and Maltese islands; and iv-v) Balkan area and Aegean islands. The mitochondrial tree exhibits some inconsistencies with the species tree that warrant future investigation. Diversification of foremost clades is estimated in a brief time body in the course of the Middle Miocene and may need been related to a interval of international local weather cooling with the institution of a marked climatic zonation in Europe.
Cladogenetic occasions inside the principle clades are scattered all through the time tree, from the Late Miocene to the Early Pleistocene, suggesting that speciation occasions in wall lizards replicate a fancy interaction between areaal topography, local weather and geological historical past reasonably than a shared main climatic or paleogeographic occasion. Our absolute time estimates, in addition to a relative courting strategy, show that the idea of a causal hyperlink between sea-level rise on the finish of the MSC and the diversification of many island endemics isn’t justified. This research reinforces the notion that a number of dispersal and vicariant occasions, at totally different time frames, are required to elucidate present allopatric distributions and to account for the historic meeting of Mediterranean biota, and cautions in opposition to the use of biogeographic calibrations primarily based on the idea of vicariance.
The 30 October 2020 Aegean Sea Tsunami: Post-Event Field Survey Along Turkish Coast
On 30 October 2020, a powerful normal-faulting earthquake struck Samos Island in Greece and İzmir Province in Turkey, each within the japanese Aegean Sea. The earthquake generated a tsunami that hit the coasts of Samos Island, Greece and İzmir, Turkey. National groups carried out two post-tsunami discipline surveys on 31 October to 1 November 2020, and 4-6 November 2020, alongside the Turkish shoreline; whereas the previous was a fast survey on the times following the tsunami, the latter concerned extra detailed measurement and investigation specializing in a ~ 110-km-long shoreline extending from Alaçatı (Çeşme District of İzmir) to Gümüldür (Menderes District of İzmir). The survey groups measured runup and tsunami heights, circulate depths, and inundation distances at greater than 120 factors at eight totally different localities.
The largest tsunami runup among the many surveyed areas was measured as 3.eight m in Akarca at a distance of 91 m from the shoreline. The most tsunami peak of 2.Three m (with a circulate depth of 1.Four m) was noticed at Kaleiçi area in Sığacık, the place probably the most extreme tsunami harm was noticed. There, the utmost runup peak was measured as 1.9 m on the northeastern facet of the bay. The survey workforce additionally investigated tsunami harm to coastal constructions, noticing a gradual lower within the affect from Gümüldür to additional southeast.
The findings of this discipline survey present insights into the coastal affect of native tsunamis within the Aegean Sea. Elucidating the genetic variation and construction of Lemnos and Lesvos sheep is vital for sustaining native genetic variety, ecosystem integrity and resilience of native meals manufacturing of the 2 North Aegean islands. In the current research, we explored genetic variety and differentiation in addition to inhabitants construction of the Lemnos and Lesvos sheep. Furthermore, we sought to determine a small panel of markers with the very best discriminatory energy to assign animals throughout islands.
Greece and Turkey Shaken by African tectonic retreat
Earthquakes are a consequence of the motions of the planet’s tectonic plates, but predicting when and the place they could happen, and learn how to put together stay some of the shortcomings of utilizing scientific data to guard human life. A devastating Mw 7.zero earthquake on October 30, 2020, offshore Samos Island, Greece was a consequence of the Aegean and Anatolian higher crust being pulled aside by north-south extensional stresses ensuing from slab rollback, the place the African plate is subducting northwards beneath Eurasia, whereas the slab is sinking by gravitational forces, inflicting it to retreat southwards.
Since the retreating African slab is coupled with the overriding plate, it tears the higher plate aside because it retreats, breaking it into quite a few small plates with frequent earthquakes alongside their boundaries. Historical earthquake swarms and deformation of the higher plate within the Aegean have been related to huge volcanism and cataclysmic devastation, such because the Mw 7.7 Amorgos earthquake in July 1956 between the islands of Naxos and Santorini (Thera).
Recombinant Feline leukemia virus Envelope glycoprotein (env) |
|||
| MBS1259177-05mgEColi | MyBiosource | 0.5mg(E-Coli) | 1100 EUR |
Recombinant Feline leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1193029-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | 1295 EUR |
Recombinant Feline leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1193029-002mgEColi | MyBiosource | 0.02mg(E-Coli) | 975 EUR |
Recombinant Feline leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1193029-002mgYeast | MyBiosource | 0.02mg(Yeast) | 1090 EUR |
Recombinant Feline leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1193029-01mgEColi | MyBiosource | 0.1mg(E-Coli) | 1140 EUR |
Recombinant Feline leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1193029-01mgYeast | MyBiosource | 0.1mg(Yeast) | 1240 EUR |
Recombinant Feline leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1147577-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Feline leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1076368-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | 1275 EUR |
Recombinant Feline leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1076368-002mgEColi | MyBiosource | 0.02mg(E-Coli) | 950 EUR |
Recombinant Feline leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1076368-002mgYeast | MyBiosource | 0.02mg(Yeast) | 1065 EUR |
Recombinant Feline leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1076368-01mgEColi | MyBiosource | 0.1mg(E-Coli) | 1115 EUR |
Recombinant Feline leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1076368-01mgYeast | MyBiosource | 0.1mg(Yeast) | 1215 EUR |
Recombinant Feline leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1228137-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Friend murine leukemia virus Envelope glycoprotein (env) |
|||
| MBS1212006-005mgBaculovirus | MyBiosource | 0.05mg(Baculovirus) | 1220 EUR |
Recombinant Friend murine leukemia virus Envelope glycoprotein (env) |
|||
| MBS1212006-005mgEColi | MyBiosource | 0.05mg(E-Coli) | 1000 EUR |
Recombinant Friend murine leukemia virus Envelope glycoprotein (env) |
|||
| MBS1212006-005mgYeast | MyBiosource | 0.05mg(Yeast) | 1105 EUR |
Recombinant Friend murine leukemia virus Envelope glycoprotein (env) |
|||
| MBS1212006-02mgEColi | MyBiosource | 0.2mg(E-Coli) | 1300 EUR |
Recombinant Friend murine leukemia virus Envelope glycoprotein (env) |
|||
| MBS1212006-05mgEColi | MyBiosource | 0.5mg(E-Coli) | 1430 EUR |
Recombinant Bovine leukemia virus Envelope glycoprotein (env), partial |
|||
| CSB-EP326185BKF | Cusabio | 10411 mg | Ask for price |
Recombinant Bovine leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1188216-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | 1145 EUR |
Recombinant Bovine leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1188216-002mgEColi | MyBiosource | 0.02mg(E-Coli) | 780 EUR |
Recombinant Bovine leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1188216-002mgYeast | MyBiosource | 0.02mg(Yeast) | 930 EUR |
Recombinant Bovine leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1188216-01mgEColi | MyBiosource | 0.1mg(E-Coli) | 935 EUR |
Recombinant Bovine leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1188216-01mgYeast | MyBiosource | 0.1mg(Yeast) | 1095 EUR |
Recombinant Bovine leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1186523-005mgBaculovirus | MyBiosource | 0.05mg(Baculovirus) | 1320 EUR |
Recombinant Bovine leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1186523-005mgMammalianCell | MyBiosource | 0.05mg(Mammalian-Cell) | 1575 EUR |
Recombinant Bovine leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1186523-05mgEColi | MyBiosource | 0.5mg(E-Coli) | 1320 EUR |
Recombinant Bovine leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1186523-05mgYeast | MyBiosource | 0.5mg(Yeast) | 1575 EUR |
Recombinant Bovine leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1186523-1mgEColi | MyBiosource | 1mg(E-Coli) | 2125 EUR |
Recombinant Bovine leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1173703-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | 1145 EUR |
Recombinant Bovine leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1173703-002mgEColi | MyBiosource | 0.02mg(E-Coli) | 780 EUR |
Recombinant Bovine leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1173703-002mgYeast | MyBiosource | 0.02mg(Yeast) | 930 EUR |
Recombinant Bovine leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1173703-01mgEColi | MyBiosource | 0.1mg(E-Coli) | 935 EUR |
Recombinant Bovine leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1173703-01mgYeast | MyBiosource | 0.1mg(Yeast) | 1095 EUR |
Recombinant Bovine leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1030040-005mgBaculovirus | MyBiosource | 0.05mg(Baculovirus) | 1320 EUR |
Recombinant Bovine leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1030040-005mgMammalianCell | MyBiosource | 0.05mg(Mammalian-Cell) | 1575 EUR |
Recombinant Bovine leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1030040-05mgEColi | MyBiosource | 0.5mg(E-Coli) | 1320 EUR |
Recombinant Bovine leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1030040-05mgYeast | MyBiosource | 0.5mg(Yeast) | 1575 EUR |
Recombinant Bovine leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1030040-1mgEColi | MyBiosource | 1mg(E-Coli) | 2120 EUR |
Recombinant Bovine leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1009526-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | 1145 EUR |
Recombinant Bovine leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1009526-002mgEColi | MyBiosource | 0.02mg(E-Coli) | 780 EUR |
Recombinant Bovine leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1009526-002mgYeast | MyBiosource | 0.02mg(Yeast) | 930 EUR |
Recombinant Bovine leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1009526-01mgEColi | MyBiosource | 0.1mg(E-Coli) | 935 EUR |
Recombinant Bovine leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1009526-01mgYeast | MyBiosource | 0.1mg(Yeast) | 1095 EUR |
Recombinant Bovine leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1149615-005mgBaculovirus | MyBiosource | 0.05mg(Baculovirus) | 1150 EUR |
Recombinant Bovine leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1149615-005mgEColi | MyBiosource | 0.05mg(E-Coli) | 785 EUR |
Recombinant Bovine leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1149615-005mgYeast | MyBiosource | 0.05mg(Yeast) | 935 EUR |
Recombinant Bovine leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1149615-02mgEColi | MyBiosource | 0.2mg(E-Coli) | 1045 EUR |
Recombinant Bovine leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1149615-05mgEColi | MyBiosource | 0.5mg(E-Coli) | 1115 EUR |
Recombinant Bovine leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1156588-005mgBaculovirus | MyBiosource | 0.05mg(Baculovirus) | 1320 EUR |
Recombinant Bovine leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1156588-005mgMammalianCell | MyBiosource | 0.05mg(Mammalian-Cell) | 1575 EUR |
Recombinant Bovine leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1156588-05mgEColi | MyBiosource | 0.5mg(E-Coli) | 1320 EUR |
Recombinant Bovine leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1156588-05mgYeast | MyBiosource | 0.5mg(Yeast) | 1575 EUR |
Recombinant Bovine leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1156588-1mgEColi | MyBiosource | 1mg(E-Coli) | 2120 EUR |
Recombinant Myeloproliferative leukemia virus Envelope glycoprotein (env) |
|||
| MBS1169545-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | 990 EUR |
Recombinant Myeloproliferative leukemia virus Envelope glycoprotein (env) |
|||
| MBS1169545-002mgEColi | MyBiosource | 0.02mg(E-Coli) | 555 EUR |
Recombinant Myeloproliferative leukemia virus Envelope glycoprotein (env) |
|||
| MBS1169545-002mgYeast | MyBiosource | 0.02mg(Yeast) | 745 EUR |
Recombinant Myeloproliferative leukemia virus Envelope glycoprotein (env) |
|||
| MBS1169545-01mgEColi | MyBiosource | 0.1mg(E-Coli) | 660 EUR |
Recombinant Myeloproliferative leukemia virus Envelope glycoprotein (env) |
|||
| MBS1169545-01mgYeast | MyBiosource | 0.1mg(Yeast) | 870 EUR |
Recombinant Feline sarcoma virus Envelope glycoprotein (env) |
|||
| MBS1145908-005mgBaculovirus | MyBiosource | 0.05mg(Baculovirus) | 1270 EUR |
Recombinant Feline sarcoma virus Envelope glycoprotein (env) |
|||
| MBS1145908-005mgEColi | MyBiosource | 0.05mg(E-Coli) | 1070 EUR |
Recombinant Feline sarcoma virus Envelope glycoprotein (env) |
|||
| MBS1145908-005mgYeast | MyBiosource | 0.05mg(Yeast) | 1125 EUR |
Recombinant Feline sarcoma virus Envelope glycoprotein (env) |
|||
| MBS1145908-02mgEColi | MyBiosource | 0.2mg(E-Coli) | 1390 EUR |
Recombinant Feline sarcoma virus Envelope glycoprotein (env) |
|||
| MBS1145908-02mgYeast | MyBiosource | 0.2mg(Yeast) | 1515 EUR |
Recombinant AKV murine leukemia virus Envelope glycoprotein (env), partial |
|||
| CSB-BP356031AGG | Cusabio | 10893 mg | Ask for price |
Recombinant AKV murine leukemia virus Envelope glycoprotein (env), partial |
|||
| CSB-EP356031AGG | Cusabio | 7105 mg | Ask for price |
Recombinant AKV murine leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1149954-002mgEColi | MyBiosource | 0.02mg(E-Coli) | 320 EUR |
Recombinant AKV murine leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1149954-01mgEColi | MyBiosource | 0.1mg(E-Coli) | 520 EUR |
Recombinant AKV murine leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1149954-1mgEColi | MyBiosource | 1mg(E-Coli) | 1925 EUR |
Recombinant AKV murine leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1149954-5x1mgEColi | MyBiosource | 5x1mg(E-Coli) | 8405 EUR |
Recombinant Gibbon ape leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1074046-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Feline foamy virus Envelope glycoprotein gp130 (env) |
|||
| MBS1130430-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Feline foamy virus Envelope glycoprotein gp130 (env) |
|||
| MBS7014273-002mg | MyBiosource | 0.02mg | 1750 EUR |
Recombinant Feline foamy virus Envelope glycoprotein gp130 (env) |
|||
| MBS7014273-01mg | MyBiosource | 0.1mg | 2705 EUR |
Recombinant Feline foamy virus Envelope glycoprotein gp130 (env) |
|||
| MBS7014273-5x01mg | MyBiosource | 5x0.1mg | 12130 EUR |
Recombinant Friend murine leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1175109-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Moloney murine leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1036922-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | 1305 EUR |
Recombinant Moloney murine leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1036922-002mgEColi | MyBiosource | 0.02mg(E-Coli) | 990 EUR |
Recombinant Moloney murine leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1036922-002mgYeast | MyBiosource | 0.02mg(Yeast) | 1100 EUR |
Recombinant Moloney murine leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1036922-01mgEColi | MyBiosource | 0.1mg(E-Coli) | 1155 EUR |
Recombinant Moloney murine leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1036922-01mgYeast | MyBiosource | 0.1mg(Yeast) | 1250 EUR |
Recombinant Kirsten murine leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1031238-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Friend murine leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1156874-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Friend murine leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1099771-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Radiation murine leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1077861-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Feline sarcoma virus Envelope glycoprotein (env), partial |
|||
| MBS1050952-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Feline sarcoma virus Envelope glycoprotein (env), partial |
|||
| MBS1115446-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Hortulanus murine leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1069463-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Feline foamy virus Envelope glycoprotein gp130 (env), partial |
|||
| MBS7070905-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant AKV murine leukemia virus Envelope glycoprotein (env), partial, Biotinylated |
|||
| CSB-EP356031AGG-B | Cusabio | 11887 mg | Ask for price |
Recombinant Human T-cell leukemia virus 1 Envelope glycoprotein gp62 (env), partial |
|||
| CSB-EP361037HQJa2 | Cusabio | 3361 mg | Ask for price |
Recombinant Human T-cell leukemia virus 1 Envelope glycoprotein gp62 (env), partial |
|||
| MBS1189464-005mgBaculovirus | MyBiosource | 0.05mg(Baculovirus) | 1125 EUR |
Recombinant Human T-cell leukemia virus 1 Envelope glycoprotein gp62 (env), partial |
|||
| MBS1189464-005mgEColi | MyBiosource | 0.05mg(E-Coli) | 815 EUR |
Recombinant Human T-cell leukemia virus 1 Envelope glycoprotein gp62 (env), partial |
|||
| MBS1189464-005mgYeast | MyBiosource | 0.05mg(Yeast) | 960 EUR |
Recombinant Human T-cell leukemia virus 1 Envelope glycoprotein gp62 (env), partial |
|||
| MBS1189464-02mgEColi | MyBiosource | 0.2mg(E-Coli) | 1085 EUR |
Recombinant Human T-cell leukemia virus 1 Envelope glycoprotein gp62 (env), partial |
|||
| MBS1189464-05mgEColi | MyBiosource | 0.5mg(E-Coli) | 1160 EUR |
Recombinant Human T-cell leukemia virus 1 Envelope glycoprotein gp62 (env), partial |
|||
| MBS1127247-005mgBaculovirus | MyBiosource | 0.05mg(Baculovirus) | 1125 EUR |
Recombinant Human T-cell leukemia virus 1 Envelope glycoprotein gp62 (env), partial |
|||
| MBS1127247-005mgEColi | MyBiosource | 0.05mg(E-Coli) | 815 EUR |
Recombinant Human T-cell leukemia virus 1 Envelope glycoprotein gp62 (env), partial |
|||
| MBS1127247-005mgYeast | MyBiosource | 0.05mg(Yeast) | 960 EUR |
Recombinant Human T-cell leukemia virus 1 Envelope glycoprotein gp62 (env), partial |
|||
| MBS1127247-02mgEColi | MyBiosource | 0.2mg(E-Coli) | 1085 EUR |
Recombinant Human T-cell leukemia virus 1 Envelope glycoprotein gp62 (env), partial |
|||
| MBS1127247-05mgEColi | MyBiosource | 0.5mg(E-Coli) | 1160 EUR |
Recombinant Human T-cell leukemia virus 1 Envelope glycoprotein gp62 (env), partial |
|||
| MBS1094485-005mgBaculovirus | MyBiosource | 0.05mg(Baculovirus) | 1125 EUR |
Recombinant Human T-cell leukemia virus 1 Envelope glycoprotein gp62 (env), partial |
|||
| MBS1094485-005mgEColi | MyBiosource | 0.05mg(E-Coli) | 815 EUR |
Recombinant Human T-cell leukemia virus 1 Envelope glycoprotein gp62 (env), partial |
|||
| MBS1094485-005mgYeast | MyBiosource | 0.05mg(Yeast) | 960 EUR |
Recombinant Human T-cell leukemia virus 1 Envelope glycoprotein gp62 (env), partial |
|||
| MBS1094485-02mgEColi | MyBiosource | 0.2mg(E-Coli) | 1085 EUR |
Recombinant Human T-cell leukemia virus 1 Envelope glycoprotein gp62 (env), partial |
|||
| MBS1094485-05mgEColi | MyBiosource | 0.5mg(E-Coli) | 1160 EUR |
Recombinant Human T-cell leukemia virus 1 Envelope glycoprotein gp62 (env), partial |
|||
| MBS1091303-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | 1170 EUR |
Recombinant Human T-cell leukemia virus 1 Envelope glycoprotein gp62 (env), partial |
|||
| MBS1091303-002mgEColi | MyBiosource | 0.02mg(E-Coli) | 815 EUR |
Recombinant Human T-cell leukemia virus 1 Envelope glycoprotein gp62 (env), partial |
|||
| MBS1091303-002mgYeast | MyBiosource | 0.02mg(Yeast) | 960 EUR |
Recombinant Human T-cell leukemia virus 1 Envelope glycoprotein gp62 (env), partial |
|||
| MBS1091303-01mgEColi | MyBiosource | 0.1mg(E-Coli) | 975 EUR |
Recombinant Human T-cell leukemia virus 1 Envelope glycoprotein gp62 (env), partial |
|||
| MBS1091303-01mgYeast | MyBiosource | 0.1mg(Yeast) | 1125 EUR |
Recombinant Human T-cell leukemia virus 2 Envelope glycoprotein gp63 (env), partial |
|||
| MBS1065567-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | 1290 EUR |
Recombinant Human T-cell leukemia virus 2 Envelope glycoprotein gp63 (env), partial |
|||
| MBS1065567-002mgEColi | MyBiosource | 0.02mg(E-Coli) | 970 EUR |
Recombinant Human T-cell leukemia virus 2 Envelope glycoprotein gp63 (env), partial |
|||
| MBS1065567-002mgYeast | MyBiosource | 0.02mg(Yeast) | 1085 EUR |
Recombinant Human T-cell leukemia virus 2 Envelope glycoprotein gp63 (env), partial |
|||
| MBS1065567-01mgEColi | MyBiosource | 0.1mg(E-Coli) | 1130 EUR |
Recombinant Human T-cell leukemia virus 2 Envelope glycoprotein gp63 (env), partial |
|||
| MBS1065567-01mgYeast | MyBiosource | 0.1mg(Yeast) | 1230 EUR |
Recombinant Human T-cell leukemia virus 1 Envelope glycoprotein gp62 (env), partial |
|||
| MBS7135833-002mgEColi | MyBiosource | 0.02mg(E-Coli) | 375 EUR |
Recombinant Human T-cell leukemia virus 1 Envelope glycoprotein gp62 (env), partial |
|||
| MBS7135833-01mgEColi | MyBiosource | 0.1mg(E-Coli) | 635 EUR |
Recombinant Human T-cell leukemia virus 1 Envelope glycoprotein gp62 (env), partial |
|||
| MBS7135833-1mgEColi | MyBiosource | 1mg(E-Coli) | 1925 EUR |
Recombinant Human T-cell leukemia virus 1 Envelope glycoprotein gp62 (env), partial |
|||
| MBS7135833-5x1mgEColi | MyBiosource | 5x1mg(E-Coli) | 8405 EUR |
Recombinant Human T-cell leukemia virus 3 Envelope glycoprotein gp63 (env), partial |
|||
| MBS1331837-005mgBaculovirus | MyBiosource | 0.05mg(Baculovirus) | 1350 EUR |
Recombinant Human T-cell leukemia virus 3 Envelope glycoprotein gp63 (env), partial |
|||
| MBS1331837-005mgMammalianCell | MyBiosource | 0.05mg(Mammalian-Cell) | 1605 EUR |
Recombinant Human T-cell leukemia virus 3 Envelope glycoprotein gp63 (env), partial |
|||
| MBS1331837-05mgEColi | MyBiosource | 0.5mg(E-Coli) | 1350 EUR |
Recombinant Human T-cell leukemia virus 3 Envelope glycoprotein gp63 (env), partial |
|||
| MBS1331837-05mgYeast | MyBiosource | 0.5mg(Yeast) | 1605 EUR |
Recombinant Human T-cell leukemia virus 3 Envelope glycoprotein gp63 (env), partial |
|||
| MBS1331837-1mgEColi | MyBiosource | 1mg(E-Coli) | 2180 EUR |
Recombinant Human T-cell leukemia virus 3 Envelope glycoprotein gp63 (env), partial |
|||
| MBS1345511-005mgBaculovirus | MyBiosource | 0.05mg(Baculovirus) | 1350 EUR |
Recombinant Human T-cell leukemia virus 3 Envelope glycoprotein gp63 (env), partial |
|||
| MBS1345511-005mgMammalianCell | MyBiosource | 0.05mg(Mammalian-Cell) | 1605 EUR |
Recombinant Human T-cell leukemia virus 3 Envelope glycoprotein gp63 (env), partial |
|||
| MBS1345511-05mgEColi | MyBiosource | 0.5mg(E-Coli) | 1350 EUR |
Recombinant Human T-cell leukemia virus 3 Envelope glycoprotein gp63 (env), partial |
|||
| MBS1345511-05mgYeast | MyBiosource | 0.5mg(Yeast) | 1605 EUR |
Recombinant Human T-cell leukemia virus 3 Envelope glycoprotein gp63 (env), partial |
|||
| MBS1345511-1mgEColi | MyBiosource | 1mg(E-Coli) | 2180 EUR |
Recombinant Feline immunodeficiency virus Envelope glycoprotein gp150 (env), partial |
|||
| MBS1046757-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Feline immunodeficiency virus Envelope glycoprotein gp150 (env), partial |
|||
| MBS1040186-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Mink cell focus-forming murine leukemia virus Envelope glycoprotein (env), partial |
|||
| MBS1133228-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Feline herpesvirus 1 Envelope glycoprotein H (gH) |
|||
| MBS7015625-002mg | MyBiosource | 0.02mg | 2210 EUR |
Recombinant Feline herpesvirus 1 Envelope glycoprotein H (gH) |
|||
| MBS7015625-01mg | MyBiosource | 0.1mg | 3130 EUR |
Recombinant Feline herpesvirus 1 Envelope glycoprotein H (gH) |
|||
| MBS7015625-5x01mg | MyBiosource | 5x0.1mg | 14050 EUR |
Recombinant Feline herpesvirus 1 Envelope glycoprotein H (gH), partial |
|||
| MBS1201030-005mgBaculovirus | MyBiosource | 0.05mg(Baculovirus) | 960 EUR |
Recombinant Feline herpesvirus 1 Envelope glycoprotein H (gH), partial |
|||
| MBS1201030-005mgMammalianCell | MyBiosource | 0.05mg(Mammalian-Cell) | 1185 EUR |
Recombinant Feline herpesvirus 1 Envelope glycoprotein H (gH), partial |
|||
| MBS1201030-05mgEColi | MyBiosource | 0.5mg(E-Coli) | 960 EUR |
Recombinant Feline herpesvirus 1 Envelope glycoprotein H (gH), partial |
|||
| MBS1201030-05mgYeast | MyBiosource | 0.5mg(Yeast) | 1185 EUR |
Recombinant Feline herpesvirus 1 Envelope glycoprotein H (gH), partial |
|||
| MBS1201030-1mgEColi | MyBiosource | 1mg(E-Coli) | 1265 EUR |
Recombinant Seoul virus Envelope glycoprotein (GP) |
|||
| MBS1192014-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Seoul virus Envelope glycoprotein (GP) |
|||
| MBS1187036-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Seoul virus Envelope glycoprotein (GP) |
|||
| MBS1053977-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Dhori virus Envelope glycoprotein (P4) |
|||
| MBS1079395-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Seoul virus Envelope glycoprotein (GP) |
|||
| MBS7015958-002mg | MyBiosource | 0.02mg | 1830 EUR |
Recombinant Seoul virus Envelope glycoprotein (GP) |
|||
| MBS7015958-01mg | MyBiosource | 0.1mg | 2765 EUR |
Recombinant Seoul virus Envelope glycoprotein (GP) |
|||
| MBS7015958-5x01mg | MyBiosource | 5x0.1mg | 12405 EUR |
Recombinant Seoul virus Envelope glycoprotein (GP) |
|||
| MBS7015959-002mg | MyBiosource | 0.02mg | 1830 EUR |
Recombinant Seoul virus Envelope glycoprotein (GP) |
|||
| MBS7015959-01mg | MyBiosource | 0.1mg | 2765 EUR |
Recombinant Seoul virus Envelope glycoprotein (GP) |
|||
| MBS7015959-5x01mg | MyBiosource | 5x0.1mg | 12405 EUR |
Recombinant Seoul virus Envelope glycoprotein (GP) |
|||
| MBS7015960-002mg | MyBiosource | 0.02mg | 1835 EUR |
Recombinant Seoul virus Envelope glycoprotein (GP) |
|||
| MBS7015960-01mg | MyBiosource | 0.1mg | 2770 EUR |
Recombinant Seoul virus Envelope glycoprotein (GP) |
|||
| MBS7015960-5x01mg | MyBiosource | 5x0.1mg | 12410 EUR |
Recombinant Dhori virus Envelope glycoprotein (P4) |
|||
| MBS7025307-002mg | MyBiosource | 0.02mg | 1850 EUR |
Recombinant Dhori virus Envelope glycoprotein (P4) |
|||
| MBS7025307-01mg | MyBiosource | 0.1mg | 2780 EUR |
Recombinant Dhori virus Envelope glycoprotein (P4) |
|||
| MBS7025307-5x01mg | MyBiosource | 5x0.1mg | 12475 EUR |
Recombinant Thogoto virus Envelope glycoprotein (P4) |
|||
| MBS1158947-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Puumala virus Envelope glycoprotein (GP) |
|||
| MBS1042848-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Puumala virus Envelope glycoprotein (GP) |
|||
| MBS1027459-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Recombinant Puumala virus Envelope glycoprotein (GP) |
|||
| MBS1052668-002mgBaculovirus | MyBiosource | 0.02mg(Baculovirus) | 1150 EUR |
Recombinant Puumala virus Envelope glycoprotein (GP) |
|||
| MBS1052668-002mgEColi | MyBiosource | 0.02mg(E-Coli) | 790 EUR |
Recombinant Puumala virus Envelope glycoprotein (GP) |
|||
| MBS1052668-002mgYeast | MyBiosource | 0.02mg(Yeast) | 940 EUR |
Even extra notable was the eruption of Santorini 3650 years in the past, which contributed to the autumn of the Minoan civilization. The Samos earthquake highlights the lengthy historic lack of appreciation of hyperlinks between deep tectonic processes and higher crustal deformation and geological hazards, and is a harbinger of future earthquakes and volcanic eruptions, establishing a foundation for research to institute higher safety of infrastructure and higher plate cultures within the area.